HC Wainwright & Co. Maintains Buy on Instil Bio, Raises Price Target to $25
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has maintained a Buy rating on Instil Bio and raised the price target from $18 to $25, indicating confidence in the company's future performance.
August 23, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has increased its price target for Instil Bio from $18 to $25, maintaining a Buy rating. This suggests a positive outlook for the company's stock.
The increase in price target from $18 to $25 by a reputable analyst firm like HC Wainwright & Co. indicates a strong positive sentiment towards Instil Bio's future performance. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100